‘The sky didn’t fall in.’

Takeaway doses for opioid pharmacotherapy increased due to COVID-19 and gave patients more flexibility, but a leading pharmacist says there is a lack of financial support The COVID-19 pandemic brought some changes relating to pharmacotherapy treatment that have been welcomed by clinicians. Dr Suzie Hudson, Clinical Director of the Network of Alcohol and other Drugs